Minor adverse events not leading to withdrawal of treatment · bacterial boils (furuncles and carbuncles)
Cefditoren pivoxil showed no clear difference in minor adverse events not leading to withdrawal of treatment… compared with cefaclor (moderate certainty).
1 finding from 1 review
Bronchopulmonary dysplasia at 28 days · symptomatic patent ductus arteriosus in preterm infants
Indomethacin showed no clear difference in bronchopulmonary dysplasia at 28 days compared with placebo or control (low certainty).
1 finding from 1 review
Incidence of pneumonia Defined as patient admitted to hospital with a diagnosis of pneumonia Dose: 2 g per day · school‐aged children (6 to 15 years) and marine corps recruits (mean age 18.5 years)
It is very uncertain whether vitamin C changes incidence of pneumonia Defined as patient admitted to hospital with… compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects (urticaria) Defined as participants reporting urticaria (hives) Dose: 2 g per day · school‐aged children (6 to 15 years) and marine corps recruits (mean age 18.5 years)
It is very uncertain whether vitamin C changes adverse effects (urticaria) Defined as participants reporting… compared with placebo (very low certainty).
1 finding from 1 review
Duration of illness · children under 5 years of age
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Duration of hospital stay (days) for 'rescue' therapy · participants with chronic neuromuscular diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospital stay (days) for 'rescue' therapy · participants with chronic neuromuscular diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to hospital discharge · people with bloodstream infections
1 finding from 1 review
Proportion of days of effective treatmenti · infants with confirmed hyperbilirubinemia
It is very uncertain whether sunlight (with or without filters or amplification) changes proportion of days of effective treatmenti compared with other sources of phototherapy (very low certainty).
1 finding from 1 review
Rate of rehospitalization within 7 days of discharge for treatment for hyperbilirubinemia · term and late preterm neonates
It is very uncertain whether sunlight (with or without filters or amplification) changes rate of rehospitalization within 7 days of discharge for treatment… compared with no treatment (very low certainty).
1 finding from 1 review
Duration of jaundice (days) · term and late preterm neonates
1 finding from 1 review
Bleeding from any location within 90 days · women undergoing breast surgery
It is very uncertain whether NSAID changes bleeding from any location within 90 days compared with other analgesic (very low certainty).
1 finding from 1 review
Bleeding from any location within 90 days · women undergoing breast surgery
NSAID showed no clear difference in bleeding from any location within 90 days compared with placebo (low certainty).
1 finding from 1 review
Incidence of breast hematoma · women undergoing breast surgery
It is very uncertain whether NSAID changes incidence of breast hematoma within 90 days of breast surgery compared with other analgesic (very low certainty).
1 finding from 1 review
Intervention not reported
Duration of delirium (days) (any time during hospital admission)
1 finding from 1 review
Intervention not reported
Length of hospital admission (days)
1 finding from 1 review
Infection rate Short term (0 to 30 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection rate Long term (30 to 365 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection rate Short term (0 to 30 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection rate Long term (30 to 365 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found